Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Dyadic International Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of DYAI: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4336−7
Shares4.46M3.83M−628.2K (−14.1%)
Value$24.8M$17.3M−$7.48M (−30.2%)

New holders (2)

Institutions that held Dyadic International Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to DYAI in Q4 2021
InstitutionSharesValue% of portfolio
Teramo Advisors, LLC10,000$45.0K0.03%
Tower Research Capital LLC (TRC)4,018$18.0K0.00%

Sold out (9)

Institutions that held Dyadic International Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of DYAI in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
FNY Investment Advisers, LLC83,500$464.0K
Ergoteles LLC78,637$437.0K
HRT Financial LP62,541$347.0K
Portolan Capital Management, LLC55,422$308.0K
Jane Street Group, LLC25,453$141.0K
Citadel Advisors LLC18,490$103.0K
Jump Financial, LLC17,204$96.0K
Group One Trading, L.P.9,610$53.0K
Cutler Group LP2,700$15.0K